Skip to main content
Log in

Timolol eye drops: Bradycardia ot tachycardia?

  • Published:
Documenta Ophthalmologica Aims and scope Submit manuscript

Abstract

26 eyes of 14 patients - 8 with primary open angle glaucoma, 6 glaucoma suspects - were treated for at least 6 months with either twice daily timolol 0.25% in both eyes or twice daily timolol 0.50% in one eye. None of the patients received concomitant local or oral drugs. Special attention was paid to tachyphylaxis and to blood pressure and pulse rate.

We could detect a slight although not significant tendency to tachyphylaxis (1–2 mm Hg) after 1 week of timolol treatment. It takes at least 1 – 2 weeks to reach the initial I.O.P. level after withdrawal of timolol therapy. Blood pressure did not change significantly. The pulse rate showed a slight although not significant tendency to decrease (a few beats/minute), but we detected a reflex tachycardia (10 beats/minute) after withdrawal of timolol therapy which was very significant. This rebound phenomenon has not been referred to in the literature. It seems reasonable to conclude that one should take care in treating glaucoma patients with concomitant arrhythmias with timolol eye drops.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Bischoff, P. Erfahrungen mit Timolol in der Glaukomtherapie. Klin. Mbl. Augenheilk. 173: 202–207 (1978).

    CAS  PubMed  Google Scholar 

  • Boger, W.P., Puliafito, C.A., Steinert, R.F. & Langston, D.P. Long-term experience with timolol ophthalmic solution in patients with open angle glaucoma. Trans. Amer. Acad. O. and O. 85: 259–267 (1978).

    Google Scholar 

  • Boger, W. P., Steinert, R.F., Puliafito, C.A. & Pavan-Langston, D. Clinical trial comparing timolol ophthalmic solution to pilocarpine in open angle glaucoma. Amer. J. Ophthal. 86: 8–18 (1978).

    Article  PubMed  Google Scholar 

  • Brogden, R.N., Speight, T.M. & Avery, G.S. Timolol: A preliminary report of its pharmacological properties and therapeutic efficacy in angina and hypertension. Drugs 9: 164–177 (1915).

    Article  Google Scholar 

  • Brenkman, R.F. Ocular hypotensive effect of atenolol 4% eye drops in glaucoma. In: Symposium on medical therapy in glaucoma. Docum. Ophthal. Proceeding Series. Vol. 12: 851–94. Dr. W. Junk, The Hague (1977).

    Google Scholar 

  • Diaz, R.G., Somberg, J. Freeman, E. & Levitt, B. Myocardial infarction after propranolol withdrawal. Amer. Heart J. 88: 257–258 (1974).

    Article  CAS  PubMed  Google Scholar 

  • Hall, R.A. Robson, R.D. & Share, N.N. A new potent beta-adrenergic blocking agent 3-morpholino4-(3-t-butylamino-2-hydroxyproproxy)-1, 2, 5-thiadiazole hydrogen maleate. Proc. Can. Fed. Biol. Soc. 13: 33 (1970).

    Google Scholar 

  • Johnson, S.H., Brubaker, R.F. & Trautman, J.C. Absence of an effect of timolol on the pupil. Invest. Ophthalmol. Visual Sci. 17: 924–926 (1978).

    CAS  Google Scholar 

  • Miller, R.R., Olson, H.G., Amsterdam, E.A. & Mason, D.T. Propranolol withdrawal rebound phenomenon. Exacerbation of coronary events after abrupt cessation of anti-anginal therapy. New England J. of Medicine 293: 416–418 (1975).

    Article  CAS  Google Scholar 

  • Moss, A.P., Ritch, R., Hargett, N.A., Kohn, A.N. & Podos, S.M. A comparison of the effects of timolol and epinephrine on intra ocular pressure. Amer. J. Ophthal. 86: 489–495 (1978).

    Article  CAS  PubMed  Google Scholar 

  • Phillips, C.I., Gore, S.M., MacDonald, M.J. & Cullen, P.M. Atenolol eye drops in glaucoma. A double masked controlled study. Brit. J. Ophthal. 61: 349–353 (1977).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Radius, R.L., Diamond, G.R., Pollack, I.P. & Langham, M.E. Timolol. A new drug for management of chronic simple glaucoma. Arch. Ophthal. 96: 1003–1008 (1978).

    Article  CAS  PubMed  Google Scholar 

  • Ritch, R., Hargett, N.A. & Podos, S.M. The effect of 1.5% timolol maleate on intraocular pressure. Acta Ophthal 56: 6–10 (1978).

    Article  CAS  PubMed  Google Scholar 

  • Ros, F.E., Drake, C.L., Offerhaus, L. & Greve, E.L. Atenolol 4% eye drops and glaucoma. Albrecht von Graefes Arch. Min. exp. Ophthal. 205: 61–70 (1977).

    Article  CAS  Google Scholar 

  • Ros, F.E., Dake, C.L., Nagelkerke, N. & Greve, E.L. Metoprolol eye drops in the treatment of glaucoma. Albrecht von Graefes Arch. klin. exp. Ophthal. 206: 247–254 (1978).

    Article  CAS  PubMed  Google Scholar 

  • Wettrell, K. & Pandolfi, M. Effect of topical atenolol on intra-ocular pressure. Brit. J. Ophthal. 61: 334–338 (1977).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zimmerman, T.J. & Kaufman, H.E. Timolol. A beta-adrenergic blocking drug for the treatment of glaucoma. Arch. Ophthal. 95: 601–604 (1977).

    Article  CAS  PubMed  Google Scholar 

  • Zimmerman, T.J. & Kaufman, H.E. Timolol. Dose response and duration of action. Arch. Ophthal. 95: 605–607 (1977).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ros, F.E., Dake, C.L. Timolol eye drops: Bradycardia ot tachycardia?. Doc Ophthalmol 48, 283–289 (1980). https://doi.org/10.1007/BF00141455

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00141455

Keywords

Navigation